Day: January 12, 2017

NORML Responds To National Academy of Sciences’ Marijuana Report

The National Academy of Sciences, Engineering, and Medicine released a comprehensive report today acknowledging that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain, and sharply criticized longstanding federal regulatory barriers to marijuana research – in particular “the classification of cannabis as a Schedule I substance” under federal law.

More bad ideas

DEA Experts Call for Better Link Between Drug and Terrorism Policy

Executive Editor Tom Julia interviewed Mike Chapman, Richard Fiano, Derek Maltz and Steve Murphy for 90 minutes about federal drug policy and how the Trump Administration can better combat the dual — and increasingly linked — threats of illicit drug trafficking and the funding […]